Author

Wander Van Breedam

Ghent UniversityORCID 0000-0001-7755-988XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Annelies Van HeckeiD· 2 shared Bert SchepensiD· 2 shared Iebe RosseyiD· 2 shared Loes van SchieiD· 2 shared Nico CallewaertiD· 2 shared Sandrine VanmarckeiD· 2 shared Simon DevosiD· 2 shared Wim NerinckxiD· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Annelies Van HeckeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologymAbsPeer-reviewedMay 21, 2023

GlycoVHH: Introducing N-glycans on the camelid VHH antibody scaffold - Optimal sites and use for macrophage delivery

Loes van Schie, Wander Van Breedam, Charlotte Roels…·Nico Callewaert

This study identifies optimal sites for introducing N-glycans on VHH antibodies to enhance macrophage delivery, demonstrating glycan-dependent uptake in vitro and in vivo.

12 citations

experimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

mouserat

𝕏 PostBluesky